FI923364A - Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet - Google Patents

Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet Download PDF

Info

Publication number
FI923364A
FI923364A FI923364A FI923364A FI923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A FI 923364 A FI923364 A FI 923364A
Authority
FI
Finland
Prior art keywords
framework
acid
acidic
neutral
pharmaceutically acceptable
Prior art date
Application number
FI923364A
Other languages
English (en)
Finnish (fi)
Other versions
FI923364A0 (fi
Inventor
Jozsef Beres
Jr Jozsef Beres
Original Assignee
Beres Export Import Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beres Export Import Rt filed Critical Beres Export Import Rt
Publication of FI923364A0 publication Critical patent/FI923364A0/fi
Publication of FI923364A publication Critical patent/FI923364A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Circuits Of Receivers In General (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Catching Or Destruction (AREA)
FI923364A 1991-07-24 1992-07-24 Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet FI923364A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU912492A HU207799B (en) 1991-07-24 1991-07-24 Process for producing pharmaceutical composition for influencing the reticuloendothelial system, for treating chronic pain symptomes of degenerative locomotor disorders or tumors, and for treating mucoviscidosis

Publications (2)

Publication Number Publication Date
FI923364A0 FI923364A0 (fi) 1992-07-24
FI923364A true FI923364A (fi) 1993-01-25

Family

ID=10959658

Family Applications (1)

Application Number Title Priority Date Filing Date
FI923364A FI923364A (fi) 1991-07-24 1992-07-24 Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet

Country Status (18)

Country Link
US (2) US5312629A (sl)
EP (1) EP0524633B1 (sl)
JP (1) JP2673852B2 (sl)
KR (1) KR100234855B1 (sl)
AT (1) ATE178213T1 (sl)
BG (1) BG61250B1 (sl)
CA (1) CA2074639C (sl)
CZ (1) CZ281672B6 (sl)
DE (1) DE69228777T2 (sl)
FI (1) FI923364A (sl)
HR (1) HRP920192B1 (sl)
HU (1) HU207799B (sl)
PL (1) PL169684B1 (sl)
RO (1) RO109505B1 (sl)
RU (1) RU2093160C1 (sl)
SI (1) SI9200155A (sl)
SK (1) SK278944B6 (sl)
YU (1) YU48243B (sl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
WO1996005867A2 (en) * 1994-08-18 1996-02-29 Nycomed Imaging A/S Compositions
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
RU2146146C1 (ru) * 1999-05-05 2000-03-10 Дубинина Лариса Васильевна Репаративно-регенеративный препарат, способ его изготовления и лечебного использования по л.в.дубининой
US20030170318A1 (en) * 2000-09-29 2003-09-11 Steiner Gregory Gene Fluoride compositions and uses thereof
US6638431B2 (en) * 2001-05-03 2003-10-28 Mainstream Engineering Corporation Formulation and method for treating wetted surface elements in climate control systems
KR20050018250A (ko) * 2003-08-14 2005-02-23 한영주 복합생약 조성물을 함유하는 항암활성을 갖는 조성물
KR100889994B1 (ko) * 2003-08-14 2009-03-24 한영미 녹반을 함유하는 항암활성을 갖는 조성물
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
CN101232821B (zh) * 2005-06-02 2013-01-23 美国硼砂公司 动物和人的骨软骨病的预防和治疗
WO2008070183A1 (en) * 2006-12-06 2008-06-12 U.S. Borax Inc. Animal feed compositions
US8008035B2 (en) 2007-01-25 2011-08-30 Roche Diagnostics Operations, Inc. Enhancement of vanadium-containing phosphatase inhibitors
EP1949894B1 (en) * 2007-01-25 2016-06-29 Roche Diagnostics GmbH Enhancement of vanadium-containing phosphatase inhibitors by polyols
US10634385B2 (en) 2009-09-03 2020-04-28 Ademco Inc. Heat balancing system
EP3428181A3 (en) 2012-05-11 2019-02-20 KAEL-GemVax Co., Ltd. Anti-inflammatory peptides and composition comprising the same
WO2014010971A1 (ko) 2012-07-11 2014-01-16 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
EP4063863A1 (en) 2013-06-07 2022-09-28 Gemvax & Kael Co., Ltd. Gv1001, gemcitabine and capecitabine for use in the treatment of pancreatic cancer in high eotaxin baseline level patients
US10561703B2 (en) 2013-06-21 2020-02-18 Gemvax & Kael Co., Ltd. Method of modulating sex hormone levels using a sex hormone secretion modulator
WO2015093854A1 (ko) 2013-12-17 2015-06-25 주식회사 카엘젬백스 전립선 암 치료용 조성물
WO2015126265A1 (en) * 2014-02-18 2015-08-27 Santos Joyce Bedelia B Oral liquid vitamin supplements containing zinc and stabilized vitamin c with reduced astringency
KR102373603B1 (ko) 2014-04-11 2022-03-14 주식회사 젬백스앤카엘 섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
EP3138399B1 (en) 2014-04-30 2023-09-06 Gemvax & Kael Co., Ltd. Composition for organ, tissue, or cell transplantation, kit, and transplantation method
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
WO2016137162A1 (ko) 2015-02-27 2016-09-01 주식회사 젬백스앤카엘 청력 손상 방어용 펩타이드 및 이를 포함하는 조성물
KR102638286B1 (ko) 2015-07-02 2024-02-20 주식회사 젬백스앤카엘 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물
ES2949697T3 (es) 2016-04-07 2023-10-02 Gemvax & Kael Co Ltd Péptido que tiene efectos de aumento de la actividad telomerasa y de extensión de los telómeros, y composición que contienen el mismo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2022998B (en) * 1978-06-14 1982-09-08 Beres J Phermaceutical composition for the treatment of neoplasticand other diseases
JPS554348A (en) * 1978-06-26 1980-01-12 Peresu Yozefu Drug composition for treating variety of illness by influence to reticuloendotherial tissue and method of treating maligmant tumor with said composition in treating human

Also Published As

Publication number Publication date
DE69228777D1 (de) 1999-05-06
CA2074639C (en) 1996-01-09
KR100234855B1 (ko) 1999-12-15
JP2673852B2 (ja) 1997-11-05
CZ281672B6 (cs) 1996-12-11
RO109505B1 (ro) 1995-03-30
EP0524633A3 (en) 1993-07-28
PL169684B1 (pl) 1996-08-30
CA2074639A1 (en) 1993-01-25
BG61250B1 (bg) 1997-04-30
HRP920192B1 (en) 2000-06-30
EP0524633A2 (en) 1993-01-27
CZ232692A3 (en) 1993-02-17
ATE178213T1 (de) 1999-04-15
EP0524633B1 (en) 1999-03-31
US5405620A (en) 1995-04-11
HUT61475A (en) 1993-01-28
YU48243B (sh) 1997-08-22
HU207799B (en) 1993-06-28
SI9200155A (en) 1993-03-31
YU81092A (sr) 1996-01-09
HRP920192A2 (hr) 1994-04-30
SK278944B6 (sk) 1998-05-06
HU912492D0 (en) 1991-12-30
RU2093160C1 (ru) 1997-10-20
BG96686A (bg) 1993-12-24
SK232692A3 (en) 1995-06-07
PL295352A1 (en) 1993-02-22
US5312629A (en) 1994-05-17
KR930001915A (ko) 1993-02-22
FI923364A0 (fi) 1992-07-24
DE69228777T2 (de) 1999-10-21
JPH06227992A (ja) 1994-08-16

Similar Documents

Publication Publication Date Title
FI923364A (fi) Foerfarande foer framstaellning av en farmaceutisk sammansaettning som paoverkar det retikuloendotela systemet
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
ES550716A0 (es) Procedimiento de preparacion de nuevos derivados tetrapep- tidos de estructura policiclica nitrogenada,asi como sus sales de adicion a un acido o una base farmaceuticamente aceptables
AU8110098A (en) A process for the preparation of macrocyclic chelants and the chelates thereof with paramagnetic metal ions
EP0543015A4 (en) Composition, method and kit for potentiating antitumor activity and for curing tumor
ZA975439B (en) New pyridyl alkane acid amides.
AU5996996A (en) Al/fe-treatment of a protein solution, followed by membrane concentration
DE69323229D1 (de) Verfahren zur Bekämpfung von Bakterien-/Pilzkrankheiten in Pflanzen
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
YU41800B (en) Process for the purification of gallium solutions
ES8303440A1 (es) "procedimiento para la preparacion de acidos oxazafosforin-4-tio-alcansulfonicos".
CA2022187A1 (en) N,n-bis-phosphonomethyl taurine n-oxide and water-soluble salts thereof
ES8500226A1 (es) Un procedimiento de preparacion de imino-2-pirrolidinas.
EP0415119A3 (en) Process for continuously removing and recovering complexing compounds from process water
AU2415699A (en) 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
DE3271447D1 (en) Cycloalkyl-(alpha-triazolyl-beta-hydroxy) ketones, process for their preparation and their use as fungicides and plant growth regulators
AU5214900A (en) Pressed products of non-caking salt
Patwardhan Glutamic-aspartic transaminase of Dolichos lablab: participation by iron as a cofactor
GB1364917A (en) Preparation of 1h-tetrazole compounds
ES2044777A1 (es) Procedimiento de obtencion de un quelato de hierro de gran solubilidad.
RU94046263A (ru) Способ удаления железа из фосфорной кислоты, полученной мокрым способом
HUP9801499A2 (hu) Metasztázisgátló gyógyászati készítmény és eljárás ennek előállítására
GB1216388A (en) A process for purifying amino acids

Legal Events

Date Code Title Description
FD Application lapsed